AusPAR: Imatinib (as mesylate)
Related information
- Australian Public Assessment Reports for prescription medicines (AusPARs)
- Browse AusPARs by active ingredient
- Browse AusPARs by product name
- Browse AusPARs by sponsor
How to access a pdf or Word document
*Large file warning: Attempting to open large files over the Internet within the browser window may cause problems. It is strongly recommended you download this document to your own computer and open from there.
Australian Public Assessment Report
11 July 2013
| AusPAR | |
|---|---|
| Active Ingredient | Imatinib (as mesylate)
|
| Product Name | Glivec
|
| Sponsor | Novartis Pharmaceuticals Australia Pty Limited
|
| Submission Number | PM-2011-02797-3-4
|
| Submission Type | Major variation (extension of duration of treatment)
|
| Decision | Approved
|
| AusPAR Date | 4 June 2013
|
| Publication Date | 11 July 2013 |